Oncology ImagingArchives
MRI accuracy for recurrence after partial gland ablation with HIFU for localized prostate cancer. A systematic review and meta-analysis
Oncology Imaging 6 min.
Prostate cancer remains the most frequently diagnosed cancer among men [1], with emerging focal therapies such as High-Intensity Focused Ultrasound (HIFU) leading the charge in minimally invasive treatment options [2]. HIFU’s appeal lies in its targeted approach, which aims to maximize tumor control...
The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification
Oncology Imaging 2 min.
With the increased utilization of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in urological practice, a pressing need to evaluate its appropriateness arises [1]. Current guidelines recommend metastatic screening in patients with newly diagnosed...
Nasopharyngeal cancer adaptive radiotherapy with CBCT-derived synthetic CT: deep learning-based auto-segmentation precision and dose calculation consistency on a C-Arm linac
Oncology Imaging 8 min.
Intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) techniques have achieved remarkable progress in NPC radiotherapy through precise dose delivery. However, NPC patients still endure persistent treatment-related toxicities, particularly xerostomia, which significantly...
Deep learning radiomics based on MRI for differentiating tongue cancer T - staging
Oncology Imaging 5 min.
Tongue cancer is one of the most common malignant tumors in the head and neck region, accounting for 25–40% of oral cancers. Its incidence is on the rise globally, especially in Asia, where it is closely related to smoking, alcohol consumption, and HPV infection [1]. Although surgical resection...
Integrating peritumor and tumor CT radiomics features in predicting local control after SBRT in patients with pulmonary oligometastases
Oncology Imaging 6 min.
Pulmonary metastases are a significant clinical challenge as the lungs are one of the most common sites for distant metastasis in various cancers [1, 2–3]. The occurrence of pulmonary metastases often signals disease progression, requiring aggressive and multidisciplinary treatment approaches [4,...
